Dear Toobiters,
In order to mitigate risks and improve your trading experience, Toobit will be adjusting the funding rate interval for TUSDT perpetual future on April 18, 2025. The funding fee settlement frequency will be adjusted from every 8 hours to every 2 hours.
The adjustment changes are as below:
|
Time
|
Maximum Funding Rate
|
|
2025.04.18 14:00 （UTC）
|
+3.00% / -3.00%
|
|
2025.04.18 16:00 （UTC）
|
+3.00% / -3.00%
|
|
2025.04.18 18:00（UTC）
|
+3.00% / -3.00%
|
|
2025.04.18 20:00（UTC）
|
+3.00% / -3.00%
|
|
......
|
|
For more information, please refer to the listing details.
Risk Reminder
1. Due to recent market volatility, please pay close attention to your positions. In order to avoid potential forced liquidation, we recommend managing your risk by closing positions, reducing leverage, or adding margin on time.
2. Toobit will make a separate announcement in the event of extreme market conditions or other special circumstances that require rule adjustments. The platform reserves the right to modify or cancel this notice at any time, at its sole discretion, without prior notice.
We appreciate your understanding and continued support. For any questions, please contact our customer support team.
Team Toobit
2025-04-18
Find us:
X: https://x.com/Toobit_official
Telegram: https://t.me/Toobit_EN
Discord: https://discord.com/invite/vvxTuGTz
YouTube: https://www.youtube.com/@Toobit_official
Reddit: https://www.reddit.com/r/toobit/
Facebook: https://www.facebook.com/toobitofficial
Medium: https://medium.com/toobit-exchange
Toobit reserves the right to modify or cancel this announcement at any time and for any reason without prior notice.
Risk Warning: The prices of digital assets may fluctuate significantly. The value of your investment may increase or decrease, and you may even lose the entire amount invested. You are solely responsible for your investment decisions, and Toobit is not liable for any losses that may occur due to the use of margin trading. This information should not be considered financial or investment advice. Please refer to our Terms of Use and Risk Disclosure for more details.